TSHA FY 2021 Earnings — Taysha Gene Therapies, Inc. Revenue & Financial Results | Market Cap Arena

TSHATaysha Gene Therapies, Inc.

$1B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$173M

Net Income

-$175M

EPS (Diluted)

$-4.64

Cash Flow

Operating Cash Flow

-$117M

Free Cash Flow

-$139M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$214M

Total Liabilities

$119M

Stockholders' Equity

$95M

Cash & Equivalents

$149M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$9,000	+100.0%
Operating Income	-$173M	-$43M	-302.9%
Net Income	-$175M	-$43M	-305.9%